Here is how AngioDynamics (ANGO) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.

AngioDynamics ANGO is preparing to release its quarterly earnings on Wednesday, 2025-04-02. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

AngioDynamics Inc. reported its fiscal second-quarter 2025 earnings, surpassing expectations with an earnings per share (EPS) of $0.03 against a forecast of -$0.11. The company also reported ...

H.C. Wainwright raised the firm’s price target on AngioDynamics (ANGO) to $16 from $15 and keeps a Buy rating on the shares. The company ...

AngioDynamics posted Q3 adjusted EPS of $0.03, beating the $(0.13) loss expected. Sales rose 9.2% to $72M, surpassing the $70.3M consensus. Med Tech net sales grew 22.2% to $31.3M, with Auryon up ...

AngioDynamics (ANGO) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to loss of $0.16 per share a year ago.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment ...

Good morning and welcome to the AngioDynamics fiscal year 20,253 quarter earnings call. (Operator Instructions) As a reminder, this conference call is being recorded. The news released detailing ...